Peter Hohenberger

Active 1988–2025

132
Papers
31,428
Citations
86
h-index
130
i10-index

Citations

Citations per year for Peter Hohenberger1926: 1 citations1989: 1 citations1990: 2 citations1991: 1 citations1992: 5 citations1994: 7 citations1995: 8 citations1996: 20 citations1997: 8 citations1998: 12 citations1999: 25 citations2000: 20 citations2001: 21 citations2002: 16 citations2003: 17 citations2004: 19 citations2005: 25 citations2006: 65 citations2007: 52 citations2008: 93 citations2009: 104 citations2010: 92 citations2011: 80 citations2012: 92 citations2013: 106 citations2014: 150 citations2015: 150 citations2016: 173 citations2017: 239 citations2018: 187 citations2019: 794 citations2020: 964 citations2021: 933 citations2022: 906 citations2023: 650 citations2024: 1,026 citations2025: 405 citations2026: 7 citations1927–1988: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,745 citing papers, 19.8% of this breakdownGermany: 775 citing papers, 8.8% of this breakdownChina: 740 citing papers, 8.4% of this breakdownItaly: 655 citing papers, 7.4% of this breakdownFrance: 629 citing papers, 7.1% of this breakdownUnited Kingdom: 528 citing papers, 6% of this breakdownNetherlands: 428 citing papers, 4.9% of this breakdownJapan: 319 citing papers, 3.6% of this breakdownSpain: 293 citing papers, 3.3% of this breakdownCanada: 223 citing papers, 2.5% of this breakdownBelgium: 211 citing papers, 2.4% of this breakdownSwitzerland: 208 citing papers, 2.4% of this breakdown
0%19.8%Other 23.4%

Fields

  • Medicine76.6%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Engineering4.4%
  • Immunology and Microbiology1.6%
  • Materials Science1.4%
  • Chemistry0.6%
  • Other1.7%

Topics

  • Sarcoma Diagnosis and Treatment12.3%
  • Gastrointestinal Tumor Research and Treatment5.9%
  • Vascular Tumors and Angiosarcomas3.3%
  • Cardiac tumors and thrombi2.6%
  • Gastrointestinal disorders and treatments2.4%
  • Gastric Cancer Management and Outcomes2.1%
  • Other71.4%

Coauthors

All papers

Open in search
  1. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 cited by 989

  2. Sarcoma classification by DNA methylation profiling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Schick, Melanie Bewerunge‐Hudler, Till Milde, Olaf Witt, Andreas E. Kulozik, Marcel Kool, Laura Romero‐Pérez, Thomas G. P. Grünewald, Thomas Kirchner, Wolfgang Wick, Michael Platten, Andreas Unterberg, Matthias Uhl, Amir Abdollahi, Jürgen Debus, Burkhard Lehner, Christian Thomas, Martin Hasselblatt, Werner Paulus, Christian Hartmann, Ori Staszewski, Marco Prinz, Jürgen Hench, Stephan Frank, Yvonne M.H. Versleijen‐Jonkers, Marije E. Weidema, Thomas Mentzel, Klaus Griewank, Enrique de Álava, Juan Díaz‐Martín, Miguel Á. Idoate, Kenneth Tou En Chang, Sharon Y. Y. Low, Adrián Cuevas-Bourdier, Michel Mittelbronn, Martin Mynarek, Stefan Rutkowski, Ulrich Schüller, Viktor Mautner, Jens Schittenhelm, Jonathan Serrano, Matija Snuderl, Reinhard Büttner, Thomas Klingebiel, Rolf Buslei, Manfred Gessler, Pieter Wesseling, Winand N.M. Dinjens, Sebastian Brandner, Zane Jaunmuktane, Iben Lyskjær, Peter Schirmacher, Albrecht Stenzinger, Benedikt Brors, Hanno Glimm, Christoph Heining, Òscar M. Tirado, Miguel Sáinz‐Jaspeado, Jaume Mora, Javier Alonso, Xavier García del Muro, Sebastián Morán, Manel Esteller, Jamal Benhamida, Marc Ladanyi, Eva Wardelmann, Cristina R. Antonescu, Adrienne M. Flanagan, Uta Dirksen, Peter Hohenberger and 11 more - Nature Communications 2021 cited by 547

  3. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lore Lapeire, Sorin Dema, Gabriel Kacsó, Lyn Austen, Laurence Moureau-Zabotto, Vincent Servois, Eva Wardelmann, Philippe Terrier, Alexander J. Lazar, Judith V.M.G. Bovée, C. Le Péchoux, Z. Papaï - The Lancet Oncology 2019 cited by 503

  4. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 1,621

  5. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 1,174

  6. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Gronchi, Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, A. López Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Ruth Ladenstein, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 cited by 455

  7. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2012 cited by 2,087

  8. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Alessandro Gronchi, Silvia Stacchiotti - Annals of Oncology 2021 cited by 563

  9. Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marinela Augustin, Walter E. Aulitzky, Peter Hohenberger, Matthias Kroiß, Peter Schirmacher, Richard F. Schlenk, Ulrich Keilholz, Frederick Klauschen, Gunnar Folprecht, Sebastian Bauer, Jens T. Siveke, Christian Brandts, Thomas Kindler, Melanie Boerries, Anna Lena Illert, Nikolas von Bubnoff, Philipp J. Jost, Karsten Spiekermann, Michael Bitzer, Klaus Schulze‐Osthoff, Christof von Kalle, Barbara Klink, Benedikt Brors, Albrecht Stenzinger, Evelin Schröck, Daniel Hübschmann, Wilko Weichert, Hanno Glimm, Stefan Fröhling - Cancer Discovery 2021 cited by 285

  10. Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 751

  11. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2012 cited by 1,401

  12. Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roberta Maestro, Rafael Marcos‐Gragera, Javier Martín‐Broto, Tomohiro Matsuda, Olivier Mir, Shreyaskumar Patel, Chandrajit P. Raut, Albiruni R. Abdul Razak, Damon R. Reed, Piotr Rutkowski, Roberta Sanfilippo, Marta Sbaraglia, Inga‐Marie Schaefer, D. Strauß, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Winette T.A. van der Graaf, Winan J. van Houdt, Otto Visser, Margaret von Mehren, Andrew J. Wagner, Breelyn A. Wilky, Young‐Joo Won, Christopher D.�M. Fletcher, Angelo Paolo Dei Tos, Annalisa Trama - Cancer 2021 cited by 227

  13. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A. Bassim Hassan, Stefanie Hecker‐Nolting, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Leo Kager, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Ruth Ladenstein, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Bruce Morland, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Sandra J. Strauss, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, Winette T.A. van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 641

  14. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 766

  15. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 cited by 306

  16. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2018 cited by 322

  17. Integrative genomic and transcriptomic analysis of leiomyosarcoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sebastian Bauer, Simon Schimmack, Alexis Ulrich, Gunhild Mechtersheimer, Karsten Rippe, Benedikt Brors, Barbara Hutter, Marcus Renner, Peter Hohenberger, Claudia Scholl, Stefan Fröhling - Nature Communications 2018 cited by 306

  18. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rebecca A. Gladdy, F. Gouin, Giovanni Grignani, J. Gutkovich, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Paul H. Huang, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Bernd Kasper, Akira Kawai, Axel Le Cesne, Franel Le Grange, Andreas Leithner, Hugh Leonard, A. Lopez Pousa, Javier Martín‐Broto, Ofer Merimsky, Priscilla Merriam, Rosalba Miceli, Olivier Mir, Michele Molinari, Michael Montemurro, Graziano Oldani, Emanuela Palmerini, Maria A. Pantaleo, S. Patel, Sophie Piperno‐Neumann, Chandrajit P. Raut, Vinod Ravi, Albiruni R. Abdul Razak, Peter Reichardt, Brian P. Rubin, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Gonzalo Sapisochín, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, William D. Tap, Annalisa Trama, Andrew Tweddle, Winette T.A. van der Graaf, Michiel A. J. van de Sande, Winan J. van Houdt, G. van Oortmerssen, Andrew J. Wagner, Markus Wartenberg, Jayne Wood, Nadia Zaffaroni, Camilla Zimmermann, Paolo G. Casali, Angelo Paolo Dei Tos, Alessandro Gronchi - ESMO Open 2021 cited by 183

  19. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS)

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Surgery 2016 cited by 548

  20. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alex J. Lazar, Robert G. Maki, Tim Mathes, Christina Messiou, Fariba Navid, Yoshihiro Nishida, Elena Palassini, Nicolas Penel, Robert Pollock, Dawid Pieper, Marlene Portnoy, Chandrajit P. Raut, Evelyne Roets, Sergio Sandrucci, Marta Sbaraglia, Silvia Stacchiotti, Katherine A. Thornton, Winette van der Graaf, Kim van der Zande, Winan J. van Houdt, Víctor M. Villalobos, Andrew J. Wagner, Eva Wardelmann, Markus Wartenberg, Sarah Watson, Aaron R. Weiss, Nikolaos Zafiropoulos - European Journal of Cancer 2020 cited by 478

  21. Gastrointestinal stromal tumour

    Authors: , , - The Lancet 2013 cited by 703

  22. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

    Authors: , , , , , , , , , , , , , - The Lancet Oncology 2012 cited by 588

  23. Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials

    Authors: , , , , , , , , - JNCI Journal of the National Cancer Institute 2007 cited by 378

  24. Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dorothea Hanf, Małgorzata Oleś, Veronica Teleanu, Michael Allgäuer, Leo Ruhnke, Oliver Kutz, Alexander Knurr, Andreas Laßmann, Volker Endris, Olaf Neumann, Roland Penzel, Kristina Beck, Daniela Richter, Ulrike Winter, Stephan Wolf, Katrin Pfütze, Christina Geörg, Bettina Meißburger, Ivo Buchhalter, Marinela Augustin, Walter E. Aulitzky, Peter Hohenberger, Matthias Kroiß, Peter Schirmacher, Richard F. Schlenk, Ulrich Keilholz, Frederick Klauschen, Gunnar Folprecht, Sebastian Bauer, Jens T. Siveke, Christian Brandts, Thomas Kindler, Melanie Boerries, Anna Lena Illert, Nikolas von Bubnoff, Philipp J. Jost, Klaus H. Metzeler, Michael Bitzer, Klaus Schulze‐Osthoff, Christof von Kalle, Benedikt Brors, Albrecht Stenzinger, Wilko Weichert, Daniel Hübschmann, Stefan Fröhling, Hanno Glimm, Evelin Schröck, Barbara Klink - Annals of Oncology 2022 cited by 80